These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 30710467)
1. Beyond medical actionability: Public perceptions of important actions in response to hypothetical genetic testing results. Seiffert DJ; McCarthy Veach P; LeRoy B; Guan W; Zierhut H J Genet Couns; 2019 Apr; 28(2):355-366. PubMed ID: 30710467 [TBL] [Abstract][Full Text] [Related]
2. Public perceptions of disease severity but not actionability correlate with interest in receiving genomic results: nonalignment with current trends in practice. Graves KD; Sinicrope PS; McCormick JB; Zhou Y; Vadaparampil ST; Lindor NM Public Health Genomics; 2015; 18(3):173-83. PubMed ID: 25790929 [TBL] [Abstract][Full Text] [Related]
3. Predispositional genome sequencing in healthy adults: design, participant characteristics, and early outcomes of the PeopleSeq Consortium. Zoltick ES; Linderman MD; McGinniss MA; Ramos E; Ball MP; Church GM; Leonard DGB; Pereira S; McGuire AL; Caskey CT; Sanderson SC; Schadt EE; Nielsen DE; Crawford SD; Green RC; Genome Med; 2019 Feb; 11(1):10. PubMed ID: 30808425 [TBL] [Abstract][Full Text] [Related]
4. When bins blur: Patient perspectives on categories of results from clinical whole genome sequencing. Jamal L; Robinson JO; Christensen KD; Blumenthal-Barby J; Slashinski MJ; Perry DL; Vassy JL; Wycliff J; Green RC; McGuire AL AJOB Empir Bioeth; 2017; 8(2):82-88. PubMed ID: 28949844 [TBL] [Abstract][Full Text] [Related]
5. Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: a randomized controlled trial. Green MJ; Peterson SK; Baker MW; Harper GR; Friedman LC; Rubinstein WS; Mauger DT JAMA; 2004 Jul; 292(4):442-52. PubMed ID: 15280342 [TBL] [Abstract][Full Text] [Related]
6. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility. American Society of Clinical Oncology J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171 [TBL] [Abstract][Full Text] [Related]
7. Attitudes towards Genetic Information Delivered by High-Throughput Sequencing among Molecular Geneticists, Genetic Counselors, Medical Advisors and Students in France. Titerlea V; Dembélé D; Mandel JL; Laporte J Eur J Med Genet; 2020 Apr; 63(4):103770. PubMed ID: 31536829 [TBL] [Abstract][Full Text] [Related]
8. Influence of individual differences in disease perception on consumer response to direct-to-consumer genomic testing. Boeldt DL; Schork NJ; Topol EJ; Bloss CS Clin Genet; 2015 Mar; 87(3):225-32. PubMed ID: 24798746 [TBL] [Abstract][Full Text] [Related]
9. Anticipating response to predictive genetic testing for Alzheimer's disease: a survey of first-degree relatives. Roberts JS Gerontologist; 2000 Feb; 40(1):43-52. PubMed ID: 10750312 [TBL] [Abstract][Full Text] [Related]
10. The general public's understanding and perception of direct-to-consumer genetic test results. Leighton JW; Valverde K; Bernhardt BA Public Health Genomics; 2012; 15(1):11-21. PubMed ID: 21720148 [TBL] [Abstract][Full Text] [Related]